3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Breast Neoplasms
2
Vulvar Neoplasms
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Stomach Neoplasms
1
Soft Tissue Neoplasms
1
Skull Base Neoplasms
1
Rectal Neoplasms
1
Neovascularization, Pathologic
1
Neoplasms
1
Intracranial Arteriovenous Malformations
1
Intracranial Aneurysm
1
Hypoparathyroidism
1
Colorectal Cancer Metastatic
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Bone Neoplasms
1
Interventions
Thyroidectomy
5
Iodine-131
5
Surgical Procedures, Operative
3
selpercatinib
2
lenvatinib
2
anlotinib
2
Ultrasonography
2
Transurethral Resection of Prostate
2
Sorafenib
2
Molecular Diagnostic Techniques
2
Interviews as Topic
2
Focus Groups
2
Biopsy, Fine-Needle
2
trastuzumab deruxtecan
1
trametinib
1
pralsetinib
1
pembrolizumab
1
gallium Ga 68 dotatate
1
dabrafenib
1
Triiodothyronine
1
Thyroxine
1
Thyrotropin Alfa
1
Surveys and Questionnaires
1
Routinely Collected Health Data
1
Radiotherapy, Adjuvant
1
Quality of Life
1
Patient Reported Outcome Measures
1
Observation
1
Nivolumab
1
Minimally Invasive Surgical Procedures
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Thyroid Neoplasms
×
Indocyanine Green
×
Clear all
NCT05328076
2024-07-05
ANGIO_PARA
IRCCS San Raffaele
Terminated
22 enrolled